Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SpaceIT Hydrogel System for Perirectal Spacing

NCT: NCT06451614 · ACTIVE_NOT_RECRUITING

NCT IDNCT06451614
StatusACTIVE_NOT_RECRUITING
Start Date2024-10-30
Completion2028-03-31

Brief Summary

To evaluate the safety and effectiveness of the SpaceIT™ Hydrogel System in patients undergoing External Beam Radiotherapy (EBRT) for the treatment of prostate cancer.

Frequently Asked Questions

What is SpaceIT Hydrogel System for Perirectal Spacing?

SpaceIT Hydrogel System for Perirectal Spacing is a clinical trial registered under NCT06451614. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06451614?

The current status of NCT06451614 (SpaceIT Hydrogel System for Perirectal Spacing) is: ACTIVE_NOT_RECRUITING.

When did SpaceIT Hydrogel System for Perirectal Spacing start?

SpaceIT Hydrogel System for Perirectal Spacing started on 2024-10-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑